verified SJR 0,619 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Mary Ann Liebert Inc.

workspace_premium Q2 — Psychiatry and Mental Health lock Subscription

Journal of Child and Adolescent Psychopharmacology

Journal of Child and Adolescent Psychopharmacology is a journal indexed in SJR in Psychiatry and Mental Health and Pediatrics, Perinatology and Child Health with an H index of 95. It has an SJR impact factor of 0,619 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,619.

Journal of Child and Adolescent Psychopharmacology focuses its scope in these topics and keywords: tic, autism, children, disorder, diagnosed, efficacy, extended, formrisk, adolescents, editorinchiefs, ...

ISSN: 1044-5463

Publisher: Mary Ann Liebert Inc.

Category: Psychiatry and Mental Health

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,619 Q2

H-index 95

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,619

H-index

Docs (year)

Docs 3y

235

Total refs

2752

Cites 3y

372

Citable 3y

183

Cites/Doc 2y

1.65

Ref/Doc

32.38

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Advances in the Psychopharmacology of Pediatric Bipolar Disorder and ADHD

Ziprasidone Monotherapy in Pediatric Bipolar Disorder

Coexistent Hypothyroidism, Psychosis, and Severe Obsessions in an Adolescent: A 10-Year Follow-up

Clozapine-Induced Neutropenia in Children: Management with Lithium Carbonate

Clinical Guidelines vs. Clinical Trials

Clinical Correlates of Episodicity in Juvenile Mania

Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review

Clinical Case Presentation: Therapeutic Challenges in Adolescent-Onset Bipolar Disorder

Can Methylphenidate Facilitate Sleep in Children with Attention Deficit Hyperactivity Disorder?

Author's Response

Atomoxetine for the Treatment of Pediatric Nocturnal Enuresis

Aripiprazole for Maladaptive Behavior in Pervasive Developmental Disorders

SHOW MORE ARTICLES

An Open Trial of Fluoxetine for Adolescents with Bulimia Nervosa

"Are ""Carve Outs"" In or Out?"

Adjunctive Donepezil in Attention Deficit Hyperactivity Disorder Youth: Case Series

A Retrospective Open Trial of Adjunctive Donepezil in Children and Adolescents with Autistic Disorder

A Retrospective Assessment of Topiramate in Children and Adolescents with Pervasive Developmental Disorders

A Preliminary Investigation of Corpus Callosum and Anterior Commissure Aberrations in Aggressive Youth with Bipolar Disorders

A Note from the Editors

A Double-Blind, Placebo-Controlled Study of Selegiline Transdermal System in Depressed Adolescents

A Cumulative Meta-Analysis of Selective Serotonin Reuptake Inhibitors in Pediatric Depression: Did Unpublished Studies Influence the Efficacy/Safety Debate?

A Comparison of Books on Bipolar Disorder in Children and Adolescents

A Case of Adolescent Body Dysmorphic Disorder Treated with Fluvoxamine

2003: Appreciations, Acknowledgments, and Announcements

FAQs

Journal of Child and Adolescent Psychopharmacology has an SJR of 0,619 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Journal of Child and Adolescent Psychopharmacology is 25%.

Journal of Child and Adolescent Psychopharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Child and Adolescent Psychopharmacology?

What is the APC / publication cost?

What is the acceptance rate?